Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chinese biotech stocks hit by a double whammy, which means it’s time to buy By: MarketWatch November 30, 2018 at 08:53 AM EST The decline in biotech stocks is more about investors fleeing a high-beta group in a risk-off environment. Read More >> Related Stocks: Alibaba Group Holding Ltd Alphabet-A Alphabet-C Amazon.com Apple Baidu.com SP ADR Beigene Ltd ADR Casi Pharmaceuticals Inc Facebook JPMorgan Chase & Co Loncar China Biopharma ETF S&P Biotech SPDR Tencent Holdings ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Chinese biotech stocks hit by a double whammy, which means it’s time to buy By: MarketWatch November 30, 2018 at 08:53 AM EST The decline in biotech stocks is more about investors fleeing a high-beta group in a risk-off environment. Read More >> Related Stocks: Alibaba Group Holding Ltd Alphabet-A Alphabet-C Amazon.com Apple Baidu.com SP ADR Beigene Ltd ADR Casi Pharmaceuticals Inc Facebook JPMorgan Chase & Co Loncar China Biopharma ETF S&P Biotech SPDR Tencent Holdings ADR